参考文献/References:
[1］郭建光．孟鲁司特联合布地奈德福莫特罗治疗小儿咳嗽变异性哮喘的疗效
及对患儿免疫功能指标的影响［J］．中国妇幼保健，2018，33(17)：3917-3919．
GUO Jianguang.Montelukast combined with budesonide formoterol in
the treatment of children with cough variant asthma and its effect on immune fun
ction indicators in children［J］．Maternal and Child Health Care of China，2018
，33 (17)：3917-3919．
[2］MURPHY K R，DHAND R，TRUDO F，et al．Therapeutic equivalence of budesoni
de/formoterol delivered via breathactuated inhaler vs Pmdi［J］．Respir Med，201
5，109(2)：170-179．
[3］韦艳征，张潇潇，朱贤桂．孟鲁司特钠联合布地奈德混悬液对小儿咳嗽变异性哮喘
的疗效观察［J］．中国医药指南，2018，16(13)：92-93．
WEI Yanzheng，ZHANG Xiaoxiao，ZHU Xiangui．Efficacy of montelukast s
odium combined with budesonide suspension in children with cough variant asthma
［J］．Guide of China Medicine，2018，16(13)：92-93．
[4］KANEMITSU Y，NIMI A，MATSUMOTO H，et al．Gastroesophageal dysmotility is
associated with the impairment of cough-specific quality of life in patients wi
th cough variant asthma［J］．Allerg Int，2016，65(3)：320-326．
[5］吴莉菁，肖国军．孟鲁司特钠片联合布地奈德混悬液治疗咳嗽变异性哮喘患儿的临
床研究［J］．中国临床药理学杂志，2016，32(22)：2032-2034，2038．
WU Lijing，XIAO Guojun．Clinical trial of montelu-kast combined wit
h budesonide in the treatment of children with cough variantion asthma［J］．Chi
nese Journal of Clinical Pharmacology，2016，32(22)：2032-2034，2038．
[6］郝伟迤．布地奈德/福莫特罗治疗咳嗽变异性哮喘的临床效果及对血清IL-4，TNF-
α 的影响［J］．解放军医药杂志，2018，30(6)：79-82．
HAO Weiyi．Clinical effecacy of budesonide/formoterol in treatment
of patients with cough variant asthma and its effect on serum IL-4 and TNF-α
［J］．Medical Journal of Chinese People’s Liberation Army，2018，30(6)：79-82
．
[7］张迎霞．孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘疗效观察［J］．中国中
西医结合儿科学，2017，9(5)：430-432．
ZHANG Yingxia．Clinical effect of montelukast sodium and budesonide
in children with cough variant asthma［J］．Chinese Pediatrics of Integrated Tra
ditional and Medicine，2017，9(5)：430-432．
[8］中华医学会儿科学分会呼吸学组，《中华儿科杂志》编辑委员会．儿童支气管哮喘
诊断与防治指南(2016年版)［J］．中华儿科杂志，2016，54(3)：167-181．
Department of Respiratory Medicine，Pediatrics Bra-nch，Chinese Med
i
cal Association，Editorial Board of “Chinese Journal of Pediatrics”．Guideline
s for Diagnosis and Prevention of Bronchial Asthma in Children (2016 Edition)［J
］．Chinese Journal of Pediatrics，2016，54(3)：167-181．
[9］李明安，司丽媛，吴红波，等．哮喘患儿外周血单个核细胞瘦素及Foxp3的表达［J
］．现代检验医学杂志，2016，31(4)：58-61，64．
LI Mingan，SI Liyuan，WU Hongbo，et al．Expression of leptin and Fox
p3 in peripheral blood mononuclear cells of children with bronchial asthma［J］
．Journal of Modern Laboratory Medicine，2016，31(4)：58-61，64．
[10］吴海丽，李贤斌．气雾型布地奈德联合孟鲁司特钠治疗小儿咳嗽变异性哮
喘疗效及对肺功能和血清炎症因子的影响［J］．海南医学院学报，2016，22(5)：467-469
，473．
WU Haili，LI Xianbin．Efficacy of aerosol budesoni-de combined with monte
lukast in treatment of children with cough variant asthma and its influence on l
ung function and serum inflammatory factor［J］．Journal of Hainan Medical Colle
ge，2016，22(5)：467-469，473．
[11］BARBOSA J S，ALMEIDA PAZ F A，BRAGA S S．Montelukast medicines of today
and tomorrow： from molecular pharmaceutics to technological formulations［J］．
Drug Deliv，2016，23(9)：3257-3265．
[12］许银姬，周明娟，梁桂兴，等．咳嗽变异性哮喘患者规范治疗2年的随访研究［J］
．广东医学，2016，37(14)：2104-2107．
XU Yinji，ZHOU Mingjuan，LIANG Guixing，et al．Standard treatment for coug
h variant asthma：A clinical trail of two years follow-up［J］．Guangdong Medic
al Journal，2016，37(14)：2104-2107．
[13］徐翼，盛泽波．孟鲁斯特钠、沙美特罗替卡松联合小剂量氨茶碱对成人咳嗽变异性
哮喘患者血清TNF-α，TGF-β1和IgE水平的影响［J］．海南医学，2017，28(20)：3272
-3275．
XU Yi，SHENG Zebo．Effects of montelukast sodium and salmeterol in combina
tion with low-dose aminophylline on serum levels of TNF-α，TGF-β1 and IgE i
n patients with adults cough variant asthma［J］．Hainan Medical Journal，2017，
28(20)：3272-3275．
[14］汤建梅．孟鲁司特钠联合布地奈德对咳嗽变异性哮喘患儿血清免疫球蛋白E、白细
胞介素-4及转化生长因子-β1水平的影响［J］．吉林医学，2017，38(3)：520-521．
TANG Jianmei．Effects of montelukast sodium combined with budesonide on se
rum immunoglobulin E，interleukin-4 and transforming growth factor-β1 levels
in children with cough variant asthma［J］．Jilin Medical Journal，2017，38(3)：
520-521．
[15］雷旭艳．儿童咳嗽变异性哮喘过敏原及血清IgE定量检测研究［J］．现代诊断与治
疗，2018，29(15)：2472-2474．
LEI Xuyan．Quantitative detection of allergens and serum IgE in children w
ith cough variant asthma［J］．Modern Diagnosis and Treatment，2018，29(15)：247
2-2474．
[16］魏延，李东升，刘建军，等．孟鲁司特钠联合布地奈德治疗儿童咳嗽变异性哮喘疗
效和安全性的Meta分析［J］．中国当代儿科杂志，2016，18(11)：1100-1105．
WEI Yan，LI Dongsheng，LIU Jianjun，et al．Therapeutic effect and safety o
f montelukast sodium combined with budesonide in children with cough variant ast
hma：A meta analysis［J］．Chinese Journal of Contemporary Pediatrics，2016，18(
11)：1100-1105．
[7］HUANG Jianping，JOCHEMS C，TALAIE T，et al．Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role［J］．Blood，2012，1
20(15)：3030-3038．
[8］LIN R J，AFSHAR-KHARGHAN V，SCHAFER A I．Paraneoplastic thrombocytosis：the secrets of tumor self-promotion［J］．Blood，2014，124(2)：184-187．
[9］郑冬菊，房磊，姬艳菊，等．平均血小板体积与早期胃癌相关性研究［J］．吉林医
学，2016，37(9)：2178-2180．
ZHENG Dongju，FANG Lei，JI Yanju，et al．Association of mean plate
let volume with early gastric cancer［J］．Jilin Medical Journal，2016，37(9)：2
178-2180．
[10］KUMARI N，DWARAKANATH B S，DAS A，et al．Role of interleukin-6
in cancer progression and therapeutic resistance［J］．Tumour Biol，2016，37(9)
：11553-11572．
[11］KOWANETZ M，WU X，LEE J，et al．Granulocyte-colony stimulating factor p
romotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes［J］．Pr
oc Natl Acad Sci USA，2010，107(50)：21248-21255．
[12］HUANG Weili，LI Yangguang，L Yongchen，et al．Use of lectin mic
roarray to differentiate gastric cancer from gastric ulcer［J］．World J Gastroe
nterol，2014，20(18)：5474-5482．
[13］成龙，李志国，李森，等．胃癌患者血小板计数与其临床病理因素的关系［J］．
哈尔滨医科大学学报，2016， 50(3)：267-270．
CHENG Long，LI Zhiguo，LI Sen，et al．Association of platelet count and cl
inicopathological factors in gastric cancer［J］．Journal of Harbin Medical Univ
ersity，2016，50(3)：267-270．
相似文献/References:
[1]邹 雪,刘 博,张婷婷,等.血清代谢物组学水平与咳嗽变异性哮喘发病风险因果关系的孟德尔随机化分析研究[J].现代检验医学杂志,2026,41(03):142.[doi:10.3969/j.issn.1671-7414.2026.03.025]
ZOU Xue,LIU Bo,ZHANG Tingting,et al.Mendelian Randomization Analysis on the Causal Relationship between Serum Metabolomics Levels and the Risk of Cough Variant Asthma[J].Journal of Modern Laboratory Medicine,2026,41(01):142.[doi:10.3969/j.issn.1671-7414.2026.03.025]